Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (361-370 of 498) with videos related to

Pageof 50
Sort By:
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601William C Jackson, Ming Tang, Matthew J Schipper, et al.
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
Pageof 50

Showing results (361-370 of 498) with videos related to

Sort By:
Pageof 50
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601William C Jackson, Ming Tang, Matthew J Schipper, et al.
JAMA Oncology|January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological FeaturesWilliam L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
Pageof 50